PrimeRFP SCOUT · Federal Contract Recompete Brief

FA810121P0012 — CADMIUM SPECIALIZED LABORATORY TESTING& BIOLOGICAL MONITORING

CADMIUM SPECIALIZED LABORATORY TESTING& BIOLOGICAL MONITORING is a federal NONE award for Department of Defense (DOD) held by PACIFIC TOXICOLOGY LABORATORIES. Estimated value $217K ($121K obligated). Current period of performance ends Oct 22, 2026. Last award drew 1 bidder. Place of performance: OKLAHOMA CITY OK.

$217K
Estimated Value
$121K
Obligated
Oct 22, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

PACIFIC TOXICOLOGY LABORATORIES holds $59K across 1 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 22, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract numberFA810121P0012
AgencyDepartment of Defense (DOD)
IncumbentPACIFIC TOXICOLOGY LABORATORIES
CAGE1DSX3
UEIHBP6R3AS1NZ4
NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301
Place of performanceOKLAHOMA CITY OK
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startApr 23, 2021
PoP end (current)Oct 22, 2026
Obligated$121K
Current value$217K
Potential value$217K

CADMIUM SPECIALIZED LABORATORY TESTING& BIOLOGICAL MONITORING

Recompete timing

Public
Expiring in 63 days

Current PoP ends Oct 22, 2026 (63 days remaining). Agencies typically plan 12–18 months ahead — at 2.1 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

PACIFIC TOXICOLOGY LABORATORIES$59K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$59K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for FA810121P0012
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open PACIFIC TOXICOLOGY LABORATORIES’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract FA810121P0012?

FA810121P0012 (CADMIUM SPECIALIZED LABORATORY TESTING& BIOLOGICAL MONITORING) is a Department of Defense (DOD) award with an estimated value of $217K, currently held by PACIFIC TOXICOLOGY LABORATORIES. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on FA810121P0012?

PACIFIC TOXICOLOGY LABORATORIES is the incumbent with $59K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 22, 2026.

When does FA810121P0012 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 22, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/FA810121P0012

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →